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Summary
Maternal b-catenin and Nodal signals are essential for
the formation of the dorsal organizer, which, in turn,
induces neural and other dorsal tissue development
in vertebrate embryos. Tob (Transducer of ErbB2) pro-
teins possess antiproliferative properties and are
known to influence BMP signaling, but their relation-
ship to other signaling pathways and to embryonic
patterning in general was unclear. In this study, we
demonstrate that zebrafish tob1a is required for cor-
rect dorsoventral patterning. Mechanistically, Tob1a
inhibits b-catenin transcriptional activity by physically
associating with b-catenin and preventing the forma-
tion of b-catenin/LEF1 complexes. Although Tob1a
can also inhibit the transcriptional activity of the Nodal
effector Smad3, its role in limiting dorsal development
is executed primarily by antagonizing the b-catenin
signal. We further demonstrate that Tob family mem-
bers across species share similar biochemical proper-
ties and biological activities.
Introduction
Vertebrate embryos are patterned along the dorsoven-
tral axis during early development. The Wnt/b-catenin
signaling pathway plays a pivotal role in dorsoventral
patterning. By acting as a downstream transcription
factor in the Wnt pathway, b-catenin is essential for
the establishment of the dorsoventral axis (Bellipanni
et al., 2006; Heasman et al., 1994; Kelly et al., 2000;
Tao et al., 2005). During early embryogenesis inXenopus
and fish, maternal b-catenin in fertilized eggs is stabi-
lized and translocated into the nuclei of blastomeres
on the dorsal side (De Robertis and Kuroda, 2004;
Schneider et al., 1996; Weaver and Kimelman, 2004),
*Correspondence: mengam@mail.tsinghua.edu.cn (A.M.); linsc@
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3 These authors contributed equally to this work.but it is degraded on the ventral side under the control
of factors such as GSK3b, CK1a, APC, and Axin (Bienz,
1999; Polakis, 2002). This asymmetrical b-catenin activ-
ity later helps to establish the dorsal organizer, a signal-
ing center in which other dorsal determinants and antag-
onists of ventralizing bone morphogenetic protein (Bmp)
signals are zygotically activated (De Robertis and
Kuroda, 2004). Therefore, the dorsalizing activity of
b-catenin appears to be primarily controlled by differen-
tial stabilization at the protein level along the dorsoven-
tral axis. It is not clear whether the dorsalizing activity of
b-catenin in these species could also be controlled by
modulation of its transcriptional activity, although its
transcriptional activity has been shown to be regulated
by Inhibitor of b-catenin and TCF (ICAT), and over-
expression of ICAT inhibits Xenopus axis formation
(Tago et al., 2000). In contrast to maternal Wnt/b-catenin
activity, zygotic Wnt/b-catenin activity, which acts after
the establishment of the dorsoventral axis, is required
for the maintenance of nonaxial mesoderm identity
and for the restriction of the size of the dorsal organizer
(Hoppler et al., 1996; Lekven et al., 2001; Ramel et al.,
2005; Ramel and Lekven, 2004).
Nodal proteins, members of the TGFb superfamily, are
essential for mesendoderm induction (Feldman et al.,
1998; Gritsman et al., 1999; Zhou et al., 1993) and are
also involved in dorsoventral patterning (Chen and
Schier, 2001; Dougan et al., 2003; Gore et al., 2005; Grits-
man et al., 2000). Nodal signals may act downstream of,
or in parallel to, b-catenin in the organizer formation
(Agius et al., 2000; Gore et al., 2005; Kelly et al., 2000;
Rex et al., 2002; Shimizu et al., 2000; Wessely et al.,
2004; Yang et al., 2002). Nodal signal transduction is me-
diated by the receptor-activated factors Smad2 and
Smad3. In zebrafish, smad2, smad3a, and smad3b are
maternally expressed (Dick et al., 2000; Pogoda and
Meyer, 2002). However, it is not known which recep-
tor-activated Smads are the major mediators of Nodal
signals during early development of zebrafish.
Tob/Tob1 was identified as an ErbB2 binding protein
that was able to inhibit the growth of NIH3T3 cells
(Matsuda et al., 1996). Human TOB is highly expressed
in quiescent T cells and is essential for suppressing
T cell activation (Tzachanis et al., 2001). Decreased
expression or inactivation of TOB in human cancer
tissues (Ito et al., 2005; Iwanaga et al., 2003) and a higher
tumor occurrence rate in Tob null mice (Yoshida et al.,
2003) both point to an antitumor effect of Tob, but the
underlying mechanisms are unclear. The developmental
function of endogenous Tob has only been studied in
mice. Tob-deficient mice have a greater bone mass,
resulting from increased numbers of osteoblasts due
to enhanced Bmp signals, indicating that Tob plays an
inhibitory role in osteoblast proliferation (Yoshida
et al., 2000). Nevertheless, Tob null embryos develop
without apparent defects (Yoshida et al., 2000), although
Tob is expressed maternally and ubiquitously in em-
bryos (Yoshida et al., 1997). It is possible that other
Tob members may compensate for Tob function during
embryogenesis. It remains unknown whether and how
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226Figure 1. Spatiotemporal Expression Pattern
of tob1a and Its Regulation
(A–K) Expression pattern of tob1a, detected
by whole-mount in situ hybridization, at indi-
cated stages. Embryo orientations: (A–F),
(H), and (J), lateral views with the animal
pole oriented at the top; (G) and (I), dorsal
views with the animal pole oriented at the
top; (K), anterior is oriented toward the left.
The indicated domains: g, germ ring; h, pre-
chordal/mesoderm/hatching gland; l, lens;
n, notochord; s, somites.
(L–P0) tob1a expression in embryos injected
with indicated mRNA species or in MZoep
mutants. Except for (L0), which is a dorsal
view, panels are shown in lateral views with
the animal pole oriented at the top and dorsal
oriented toward the right. (L–P) show the
shield stages; (L0–P0) show the 75% epiboly
stage. Injection doses: sqt, 0.5 pg; lefty1,
50 pg; b-catDN, 10 pg; bcat2MO, 20 ng.Tob members are involved in the early development of
vertebrate embryos.
Here, we report that tob1a, a maternally expressed
Tob member, is required for proper dorsoventral pat-
terning of zebrafish embryos. Overexpression of tob1a
causes ventralized phenotypes, while tob1a knockdown
leads to embryonic dorsalization. Tob1a binds to b-cat-
enin and blocks the formation of the b-catenin/LEF1
transcriptional complexes, which provides another
mechanism for limiting the dorsalizing activity of b-cate-
nin. Additionally, Tob1a inhibits Smad3-induced embry-
onic dorsalization by physically interacting with and pre-
venting Smad3 from binding to one of its cofactors,
p300.
Results
Spatiotemporal Expression of tob1a
We identified zebrafish tob1a by screening a zebrafish
cDNA library and using tob1b as a probe. The zebrafish
Tob1a protein shares a sequence identity of 79.6%,
81.4%, and 79.3% to zebrafish Tob1b, human TOB1,
and mouse Tob/Tob1, respectively.
We examined the spatiotemporal expression pattern
of tob1a during zebrafish embryogenesis by using
whole-mount in situ hybridization. Similar to tob1b, the
tob1a transcript is present in the fertilized eggs and in
all blastodermal cells at the 1000-cell and the 30% epib-
oly stages (Figures 1A–1C). At around the 40% epiboly
stage, tob1a expression becomes restricted to the
germ ring, where mesoderm precursors reside (Fig-
ure 1D). During gastrulation and segmentation, tob1a
is expressed in the prechordal mesoderm/hatching
gland, the notochord, and the tail bud (Figures 1E–1J),
and it exhibits a different expression pattern from that
of tob1b during the same periods (Shi et al., 2004). At
24 hr postfertilization (hpf), tob1a expression was de-
tected primarily in the hatching gland, the lens, somites,
and the notochord (Figure 1K).We next tested how tob1a expression was regulated
by examining the probable regulatory roles of the major
signaling pathways involved in early embryonic devel-
opment. The expression of tobla during gastrulation
was induced by overexpression of the Nodal ligand
squint (sqt) (Figures 1L and 1L0), but it was inhibited by
overexpression of the Nodal antagonist lefty1 (Figures
1M and 1M0) and in Nodal-deficient MZoep mutant em-
bryos (Figures 1N and 1N0), suggesting that Nodal sig-
naling is required for maintaining zygotic tob1a expres-
sion. However, the level of maternal tob1a mRNA was
not reduced in MZoep mutants (data not shown), sug-
gesting that maternal tob1a expression is Nodal inde-
pendent. Likewise, overexpression of b-cateninDN
mRNA, which encodes a constitutively active b-catenin
lacking the first 45 N-terminal residues, induced ectopic
expression of tob1a (Figures 1O and 1O0). Conversely,
when Wnt/b-catenin signaling was blocked by injecting
a b-catenin-2 morpholino, tob1a expression was in-
hibited (Figures 1P and 1P0). Taken together, our data
suggest that both Nodal and canonical Wnt signals are
required for sustaining zygotic tob1a expression. We
found that tob1a expression in embryos injected with
bmp2b mRNA or in swirl mutants that are homozygous
for a bmp2bmutation (Kishimoto et al., 1997) was not al-
tered (data not shown), implying that zygotic expression
of tob1a may be independent of Bmp signals.
Tob1a Has Ventralizing Activity in Embryonic
Patterning
To investigate the role of tob1a in embryonic develop-
ment, we first injected zebrafish embryos with synthetic
tob1a mRNA. Injection with 400 ng tob1a mRNA caused
53% of the embryos to lose their head and notochord at
24 hpf (Figure 2B; Figure S1, see the Supplemental Data
available with this article online); these phenotypes are
characteristic of embryonic ventralization and resemble
those seen in ichabod mutant embryos that lack mater-
nal b-catenin-2 expression (Bellipanni et al., 2006; Kelly
Tob1 Antagonizes b-Catenin Activity
227Figure 2. Effects of tob1a Overexpression and Knockdown in Zebrafish Embryos
(A–H) Lateral views of live embryos at (A–D) 24 hpf or at the (E–G) 6-somite stage. (A) Wild-type embryo. A caudal ventral region was enlarged in
the insert so that the notochord (n) and the caudal ventral fin (cvf) can be seen (same for other pictures). (B) Injection with 400 pg tob1a mRNA
resulted in loss of the head and notochord. (C) Injection with 12 ng tob1a-MO led to loss of the caudal ventral fin. Data were averaged from three
independent experiments and are expressed as means plus standard deviations. (D) An embryo coinjected with 100 pg tob1a mRNA and 12 ng
tob1a-MO showed normal morphology. Data were averaged from three independent experiments and are expressed as means plus standard
deviations. (E) Wild-type embryos. (F) Embryos injected with 12 ng tob1a-MO showed early tail protrusion. (G) Embryos coinjected with 100
pg tob1a mRNA and 12 ng tob1a-MO had normal morphology. (H) The ratios of dorsalized embryos, as shown in (F), in three independent ex-
periments after injections. Data were averaged from three independent experiments and are expressed as means plus standard deviations. The
number of calculated embryos is indicated below each bar.
(I–O0 0) Expression patterns of marker genes in (I–O) wild-type or embryos injected with either (I0–O0) 400 pg tob1a mRNA or (I0 0–O0 0) 15 ng tob1a-
MO. Embryos for chordin, otx2, and eve1 are shown in animal pole views with dorsal oriented toward the right; the embryo for goosecoid is
shown in a dorsal view with the animal pole oriented toward the top; and embryos for bmp2b and gata2 are shown in lateral views with dorsal
oriented toward the right. Developmental stages are indicated at the bottom. Relevant statistical data are presented in Figure S1.et al., 2000). The expression of the shield-specific genes
chordin and goosecoid was decreased at the shield
stage (Figures 2I0 and 2J0), and the expression of the an-
terior neuroectoderm marker otx2 was also decreased
at the bud stage (Figure 2K0). In contrast, the ventral
markers bmp2, eve1, and gata2 expanded dorsally dur-
ing gastrulation, and the hematopoietic marker gata1
had a larger expression domain in the blood island at
24 hpf (Figures 2L0–2O0). The ratios of embryos with al-
tered marker gene expression are summarized in
Figure S1. These results indicate that tob1a overexpres-
sion is able to ventralize embryos.
To investigate the role of endogenous tob1a, a mor-
pholino antisense oligonucleotide (tob1a-MO), which
was able to block production of the Tob1a-GFP fusion
protein from a tob1a-GFP fusion expression plasmid
(data not shown), was injected into one-cell embryos.
Embryos injected with 12 ng tob1a-MO exhibited weakly
dorsalized phenotypes: premature detachment of the
tailbud from the yolk at the 5–10 somite stages
(Figure 2F), in contrast to tight attachment of the tailbud
around the yolk in control embryos (Figure 2E), and par-tial loss of the caudal ventral fin at 24 hpf (Figure 2C).
These dorsalized phenotypes are characteristic of
weakly dorsalized phenotypes (C1 and C2 classes),
reminiscent of mini fin (mfn) and lost-a-fin (laf) mutant
embryos, which were first described by Mullins et al.
(1996) and were subsequently found to be caused by in-
efficient Bmp signaling (Bauer et al., 2001; Connors
et al., 1999; Mintzer et al., 2001). The tob1-MO-induced
dorsalization could be neutralized by coinjection with
a smaller amount of tob1a mRNA (100 pg) (Figures 2D,
2G, and 2H), suggesting that tob1-MO specifically tar-
gets tob1a. We also noted that when the dose of
tob1a-MO increased to 15 ng, the injected embryos dis-
played severely dorsalized phenotypes, including com-
plete loss of the ventral tail fin and a shorter and twisted
tail (Figure S1). The effects of tob1a knockdown on the
expression of the marker genes (Figures 2I0 0–2O0 0;
Figure S1) tend to be opposite to those of tob1a overex-
pression. In contrast, injection with 15 ng of a control
morpholino, which has six mismatched nucleotides
from tob1a-MO, did not cause developmental defects
(Figure S1). These results suggest that tob1a function
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fish embryos.
Tob1a Binds to and Attenuates the Transcriptional
Activity of b-Catenin
To find clues for the mechanisms underlying tob1a func-
tion, we went on to identify Tob1a-interacting proteins
by using yeast two-hybrid screening and Tob1a as
bait. One of the identified Tob1a binding proteins is
b-catenin. To confirm their physical interaction, we per-
formed reciprocal immunoprecipitation of overex-
pressed Myc-Tob1a and Flag-b-catenin in mammalian
cells. The result indicated that Myc-Tob1a was coimmu-
noprecipitated with Flag-b-catenin (Figure 3A). Immu-
nostaining in HeLa cells revealed that Tob1a was lo-
cated in both the cytoplasm and nuclei, and that
Tob1a overlapped well with b-catenin in the nucleus
(Figure 3B). Thus, b-catenin is a binding partner of
Tob1a.
We then investigated the effect of Tob1a on b-catenin-
mediated Wnt signaling by using the Wnt signal-respon-
sive reporter LEF1-luciferase. In transfected mammalian
cells, luciferase expression was induced by overexpres-
sion of b-catenin and LEF1, but this induction was in-
hibited by coexpression of tob1a in a dose-dependent
manner (Figure 3C). When the LEF1-luciferase DNA
was injected into single-cell embryos, luciferase expres-
sion was induced by endogenous Wnt signaling at the
bud stage (Figure 3D). The reporter expression in em-
bryos was inhibited by overexpression of tob1a
mRNA, but it was enhanced by knockdown of tob1a. Ap-
parently, Tob1a negatively regulates canonical Wnt sig-
naling both in vitro and in vivo.
The next question is how Tob1a inhibits b-catenin-
mediated canonical Wnt signaling. It has been known
that cytoplasmic b-catenin degrades in the absence of
Wnt signals through the formation of b-catenin/Axin/
GSK/APC complexes, and that activation of Wnt signal-
ing allows for the release of b-catenin from the degrada-
tion complexes, followed by translocation into the nu-
cleus (Logan and Nusse, 2004). The nuclear b-catenin
interacts with the transcription factor LEF1 to activate
target gene expression (Behrens et al., 1996; Hsu
et al., 1998). Our domain-based mutagenesis analyses
revealed that the armadillo repeats 4–6 of b-catenin, a re-
gion that is required for binding LEF1/TCF factors, were
obligatory for Tob1a binding (Figure S2) (Graham et al.,
2000; von Kries et al., 2000). Thus, Tob1a may compete
with LEF1/TCF for b-catenin. Immunoprecipitation ex-
periments in mammalian cells revealed that the amount
of HA-LEF1 coimmunoprecipitated with Flag-b-catenin
decreased in the presence of the increasing amount of
Myc-Tob1a (Figure 3E), although neither the Flag-b-cat-
enin level nor the HA-LEF1 level in total cell lysates was
altered. Of note, we did not detect any direct binding of
Tob1a to LEF1 (data not shown). These results suggest
that Tob1a inhibits the interaction between b-catenin
and LEF1 solely by competing with LEF1 for b-catenin.
The possibility that Tob1a has a role in b-catenin degra-
dation was tested by coimmunoprecipitation of b-cate-
nin and its degradation complex components Axin and
APC in mammalian cells. It was found that overexpres-
sion of Myc-Tob1a had no effect on b-catenin binding
to APC or Axin (Figure S3). Taken together, these datasuggest that Tob1a inhibits the transcriptional activity
of b-catenin by preventing b-catenin from binding to
a LEF1/TCF factor. The same mechanism is also used
by another b-catenin antagonist, ICAT (Tago et al.,
2000).
To further consolidate a competitive role of Tob1a
against b-catenin/LEF complex formation, we per-
formed a series of experiments to identify the interacting
interface and functional domains of Tob1a that are re-
quired for antagonizing the transcriptional activity of
b-catenin (Figures 3F–3H). Tob1a mutants ND5, MD2,
and MD4, all of which lack the Box B domain that is
conserved among Tob family members, failed to bind
to b-catenin, while other deletion mutants retained the
ability to bind b-catenin (Figure 3G). Furthermore, overex-
pression of ND5, MD2, or MD4 did not inhibit b-catenin/
LEF1-induced Wnt reporter expression in mammalian
cells. Therefore, the Box B domain of Tob1a is responsi-
ble for b-catenin interaction and is essential for confer-
ring its anti-b-catenin activity.
Tob1a Antagonizes the Dorsalizing Activity
of Maternal b-Catenin in Zebrafish Embryos
We next tested the genetic interaction between tob1a
and b-catenin-mediated Wnt signaling that is essential
for the formation of the dorsal organizer. Injection with
5 pg zebrafish b-cateninDNmRNA led to dorsalized phe-
notypes at the 5-somite stage, including abnormal ante-
rodorsal accumulation of cells, epiboly arrest, and even
two body axes (Figures 4A, 4C, and 4E). Overexpression
of b-cateninDN also enhanced expression of the dorsal
marker chordin, the axial mesoderm marker no tail
(ntl), and the anterior neuroectodermal marker otx2, but
it inhibited expression of the ventral markers bmp2,
eve1, and gata2 (Figures 4A–4D). When the same
amount of b-cateninDN mRNA and 100 pg tob1a
mRNA were coinjected, the majority of embryos had
normal morphology and marker gene expression (Fig-
ures 4A–4D). In contrast, coinjection with tob1a-MO
and b-cateninDN caused more severe dorsalized phe-
notypes and greater changes in marker gene expression
(Figures 4A–4D). In addition, tob1a-MO and b-cateninDN
coinjection led to an increased percentage of embryos
with two axes (Figure 4E). These results suggest that
tob1a can antagonize the dorsalizing activity of b-cate-
nin during the early development of zebrafish embryos.
In zebrafish, the maternal effect mutation ichabod re-
sults in severely ventralized phenotypes with loss or a re-
duction of dorsoanterior derivatives due to decreased
maternal expression of b-catenin-2 (Bellipanni et al.,
2006; Kelly et al., 2000). Morpholino knockdown of
b-catenin-2 causes the same ventralized phenotypes
seen in ichabod (Bellipanni et al., 2006). We used a
b-catenin-2 morpholino (bcat2MO) to further investigate
the interaction between the maternal b-catenin signal
and tob1a (Figure 5A). Embryos injected with tob1a-
MO showed not only expansion of chordin and otx2
expression, but increased expression of bozozok (boz),
which is a direct target of the maternal b-catenin signal
(Leung et al., 2003; Ryu et al., 2001). In addition,
tob1a-MO injection caused the expression domain of
the posterior neuroectoderm marker hoxb1b to expand
ventrally with vegetal shift of its anterior border. On the
other hand, injection with 20 ng bcat2MO abolished
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Unless otherwise stated, the following assays were performed in human HEK293T cells.
(A) Interaction between Myc-tob1a and Flag-b-catenin. TCL indicates total cell lysate, which is consistently used hereafter.
(B) Colocalization of overexpressed Myc-tob1a (red) and HA-b-catenin (green) in HeLa cells. DAPI was used to identify nuclei.
(C) b-catenin/LEF1-stimulated expression of the LEF1-luciferase reporter was inhibited by cotransfection of tob1a plasmid DNA at 100 ng (+), 200
ng (++), or 300 ng (+++).
(D) Expression of the LEF1-luciferase reporter in zebrafish embryos was inhibited by tob1a mRNA injection at 150 pg (+), 300 pg (++), or 450 pg
(+++), but it was enhanced by injection with 15 ng tob1a-MO. Embryos were injected at the one-cell stage, and luciferase activity was analyzed at
the bud stage.
(E) Tob1a suppressed association of b-catenin with LEF1. Myc-tob1a doses: 1 mg and 3 mg, respectively.
(F) Schematic of different tob1a deletion constructs. NES, nuclear exportation signal; NLS, nuclear localization signal; NRC, nuclear receptor
coactivator binding domain; Ub, ubquitination domain.
(G) Interactions between Myc-b-catenin and different Tob1a deletion mutants with HA tag.
(H) Effect of different Tob1a deletion mutants on b-catenin/LEF1-stimulated expression of the LEF1-luciferase reporter. Note that the mutants
ND5, MD2, and MD4, all of which lack the Box B domain, failed to inhibit the reporter activation.expression of boz, chordin, otx2, and hoxb1b. The ex-
pression of these markers was not recovered by simul-
taneous knockdown of tob1a and b-catenin-2, suggest-
ing that tob1a genetically acts upstream of b-catenin-2,consistent with a direct inhibitory effect of Tob1a on the
transcriptional activity of b-catenin.
We tested for any effect of overexpression of several
tob1a deletion mutants in zebrafish embryos. Like
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Injection doses: 5 pg for b-catDN mRNA, 100 pg for tob1a mRNA, and 15 ng for tob1a-MO.
(A) Morphology of live embryos at the 5-somite stage.
(B) Expression of the marker genes (indicated on the top) at the indicated stages (bottom). Orientations of embryos: animal pole views with dorsal
oriented toward the right for chordin and eve1; dorsoanterior views for otx2; dorsal views with the animal pole oriented toward the top for ntl; and
lateral views with dorsal oriented toward the right for bmp2 and gata2.
(C and D) Statistical data for (A) and (B), respectively.
(E) The ratios of embryos with duplicated axes that were recognized by morphological observation at the 5-somite stage or molecular examinations.full-length tob1a, overexpression of the C-terminal-trun-
cated mutant CD2, which retains the first 112 residues
and inhibitory activity in vitro (Figures 4F and 4G), caused
a decrease of the dorsal markers boz, chordin, and gsc in
71%(n = 34), 66%(n= 29), and46% (n = 26)of the embryos
(Figure 5B), respectively. However, overexpression of ei-
ther the mutant ND5, which lacks the first 105 residues
at the N terminus, or the mutant MD4, which lacks the
Box B domain required for binding b-catenin, resulted in
a slight decrease in expression of these markers in only
7%–15% of the embryos (n = 27–33) (Figure 5B). These
results imply that direct binding of Tob1a to b-catenin is
required for inhibiting dorsal development in vivo.
We also examined genetic interactions between tob1a
and other mediators or targets of the Wnt/b-catenin sig-
naling pathway. It was noted that lef1 overexpressionalleviated the ventralizing effect of tob1a overexpres-
sion (Figure S4A). Overexpression of a dominant nega-
tive LEF/TCF protein (tcf3DN) inhibited expression of
chordin, and this effect was not rescued by tob1a
knockdown (Figure S4B and legend). This result is as
expected since Tcf3DN can bind to the target promoters
but is unable to bind b-catenin. Together, these obser-
vations support the notion that tob1a inhibits dorsal
development of the zebrafish embryo by antagonizing
Wnt/b-catenin signals.
tob1a May Control Zygotic Wnt/b-Catenin Signals
for Ventrolateral Mesodermal Development
during Gastrulation
To investigate the involvement of tob1a in regulating
Wnt8-stimulated zygotic Wnt/b-catenin activity, tob1a
Tob1 Antagonizes b-Catenin Activity
231Figure 5. Genetic Interactions between tob1a and Maternal or Zygotic Wnt/b-Catenin Signals
(A) Interaction between tob1a and maternal Wnt/b-catenin activity. After injection with 20 ng bcat2MO, 20 ng tob1a-MO, or both (indicated on the
top) at the one-cell stage, embryos were examined for boz and chordin (chd) expression at the 30% epiboly stage and for otx2 and hoxb1b ex-
pression at the 90% epiboly stage (indicated on the right). Embryos are shown in lateral views with dorsal oriented toward the right for boz and
hoxb1b, in animal pole views with dorsal oriented toward right for chd, and in anterodorsal views with anterior oriented toward the top for otx2.
(B) Effect of overexpression of tob1a mutants on early dorsoventral patterning. Embryos were injected with 400 pg of each mRNA species at the
one-cell stage and were examined for boz expression at the oblong stage and for chd and goosecoid (gsc) expression at the shield stage. Em-
bryos are shown in lateral views with dorsal oriented toward the right for boz, in animal pole views with dorsal oriented toward the right for chd,
and in dorsal views with animal pole oriented toward the top for gsc. For details for tob1a mutants, see Figure 3F.
(C) Interaction between tob1a and zygotic Wnt/b-catenin activity. Injections were done at the one-cell stage at the dose of 20 ng for tob1a-MO,
8 ng for wnt8MO2, or 400 pg for tob1amRNA. Embryos are shown in dorsal views with dorsal oriented toward the right for chd at the shield stage,
in lateral views with dorsal oriented toward the right for tbx6 at the 75% epiboly stage, and in anterodorsal views with anterior oriented toward the
top for otx2 at the 90% epiboly stage.knockdown was performed along with and in combina-
tion with wnt8 knockdown by using wnt8MO2 (Lekven
et al., 2001), which was followed by examination of a
set of markers (Figure 5C). The expression of boz was
increased in late blastulas by tob1a knockdown (Fig-
ure 5A), but it was not affected by wnt8 knockdown
(data not shown). This could be explained by the fact
that tob1a only affects maternal Wnt/b-catenin activity
when the zygotic Wnt/b-catenin signal is not available
at such early stages. The expression domains of chordin
at the shield stage and otx2 at the bud stage were ex-
panded by either tob1a or wnt8 knockdown, and they
were further expanded by simultaneous knockdown of
tob1a and wnt8, which excludes the possibility that
tob1a primarily inhibits endogenous Wnt8 activity in
dorsal and anterior neuroectodermal development.
The expression of the ventrolateral mesoderm marker
tbx6 was markedly reduced by wnt8 knockdown.
Knockdown of tob1a appeared to slightly enhancetbx6 expression and partially rescued the effects of
wnt8 knockdown on tbx6, indicating that tob1a may in-
hibit zygotic Wnt/b-catenin activity in ventrolateral me-
sodermal development. Ectopic expression of tob1a
suppressed a wnt8 knockdown-induced increase of
chordin and otx2 expression, but it strengthened the in-
hibitory effect of wnt8 knockdown on tbx6. This sug-
gests that, in the absence of Wnt8 activity, ectopic
tob1a is still able to inhibit maternal Wnt/b-catenin in
the organizer formation as well as zygotic Wnt/b-catenin
in ventrolateral mesodermal development. Alternatively,
these results may point to additional, Wnt-independent
roles for tob1a in the mesoderm, and we examine this
possibility below.
Tob1a Inhibits Smad3-Mediated TGFb Signaling
Yoshida et al. (2000) have previously demonstrated that
mouse Tob1 binds various Smads, and that Tob1
inhibits Bmp signaling in vitro. We found that in
Developmental Cell
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(A) Interactions of Tob1a with different mammalian Smads in HEK293T cells.
(B) Zebrafish Tob1a-Smad3a or Tob1a-Smad3b interactions in HEK293T cells.
(C) Overexpression of tob1a attenuated caALK4-stimulated expression of the reporter CAGA12-luciferase in Mv1lu cells. Data were averaged
from three independent experiments and are expressed as means plus standard deviations.
(D) Overexpression of tob1a attenuated Smad3-stimulated CAGA12-luciferase expression in Mv1lu cells. Data were averaged from three inde-
pendent experiments and are expressed as means plus standard deviations.
(E) CAGA12-luciferase expression in zebrafish embryos was inhibited by injecting 400 pg tob1a mRNA, but it was enhanced by injecting 15 ng
tob1a-MO. Data were averaged from three independent experiments and are expressed as means plus standard deviations.
(F) Mapping of Smad3 domains that are required for binding Tob1a. Note that only the MH2 or the Linker plus MH2 domains was strongly bound
to Tob1a (indicated by arrows), while the MH1 plus Linker was weakly bound to Tob1a.
(G) Binding of HA-Smad3 to Flag-p300-CT (containing the C-terminal region of p300) was inhibited by coexpression of an increasing amount of
tob1a (0.5 mg, 1 mg, and 4 mg) in HEK293T cells. The band for HA-Smad3/Flag-p300-CT complexes is indicated by an arrow.
(H) Morphological changes in injected embryos at the 5-somite stage. Embryos injected with 50 pg smad3b mRNA were remarkably elongated
(middle, top panel); this phenotype was alleviated by coinjection with 100 pg tob1a mRNA (right, top panel). Injection with 25 pg smad3b mRNA
caused a less severe dorsalized phenotype (middle, bottom panel), which was strengthened by coinjection with 15 ng tob1a-MO (right, bottom
panel).
(I) Changes in expression of marker genes at the shield stage. Injection with 50 pg smad3b resulted in the expansion of expression domains of the
dorsal markers chordin and gsc and the reduction of expression of the ventral markers eve1 and gata2. Effects of smad3b overexpression were
enhanced by injection with 15 ng tob1-MO, but they were inhibited by injection with 100 pg tob1amRNA. Embryos are shown in dorsal views with
the animal pole oriented toward the top for chordin, in animal pole views with dorsal oriented toward the right for gsc and eve1, or in lateral views
with dorsal oriented toward the right for gata2. Corresponding statistical data are shown in Figure S8.HEK293T cells overexpressed Tob1a strongly bound to
Smad3, Smad4, Smad6, and Smad7 and weakly bound
to Smad1 and Smad2; however, binding to Smad5 was
almost undetectable (Figure 6A). Furthermore, Tob1a
interacted with both zebrafish Smad3a and Smad3b
(Figure 6B).We then determined the effect of Tob1a on Bmp
signaling by using the reporter BRE-luciferase that con-
tains Bmp-specific responsive elements (BRE). In cul-
tured HepG2 cells, tob1a overexpression inhibited the
luciferase expression induced by a constitutively active
Bmp receptor, BMPRIA-QD (Figure S5), which was
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233consistent with the effect of mouse Tob1 on Bmp signal-
ing (Yoshida et al., 2000). In zebrafish embryos, how-
ever, BRE-luciferase expression was stimulated by
tob1a overexpression, but it was inhibited by tob1a
knockdown.
The effect of tob1a on TGFb signaling was tested by
using the reporter CAGA12-luciferase, which includes
12 tandem repeats of the Smad binding site (CAGA) in
the promoter (Dennler et al., 1998). The expression of
this reporter was stimulated by overexpression of the
constitutively active ALK4 or Smad3 in Mv1lu cells.
The ALK4-induced reporter expression was slightly
attenuated by coexpression of tob1a (Figure 6C). How-
ever, the Smad3-induced reporter expression was
more drastically inhibited by coexpression of tob1a (Fig-
ure 6D), implying that Tob1a suppresses Smad3 activity
more effectively. In zebrafish embryos, the expression
of the same reporter was inhibited by tob1a overexpres-
sion, but it was enhanced by tob1a knockdown (Fig-
ure 6E). These data suggest that Tob1 acts as a negative
regulator of TGFb signals in vitro as well as in vivo.
To understand the mechanism underlying negative
regulation of TGFb signaling by Tob1a, the effect of
Tob1a on Smad3 activity was investigated. We did not
test the effect of Smad2 because it interacted with
Tob1a weakly and its roles in the development of zebra-
fish embryos are uncertain. The Smad3 binding domain
of Tob1a was mapped to the Box B domain (Figure S6A),
which is also essential for associating with b-catenin
(Figures 3F and 3G). The amount of Flag-Smad3 bound
to HA-Tob1a was progressively reduced when levels
of coexpressed Myc-b-catenin increased (Figure S6B),
suggesting that a competition between Smad3 and
b-catenin for Tob1a binding may exist. The Tob1a bind-
ing domain of Smad3 was mapped to the MH2 domain
(Figure 6F), which is responsible for interaction with
and activation by the type I receptor, formation of homo-
meric and heteromeric Smad complexes, nucleocyto-
plasmic shuttling, and interaction with transcription
cofactors or corepressors (Shi and Massague, 2003). We
asked if the interaction between Tob1a and the MH2 do-
main of Smad3 affected the association of Smad3 with
other binding partners or Smad3 activation. Our data
demonstrated that tob1a overexpression in mammalian
cells had no effect on Smad3 association with caALK4
(Figure S7), the level of phosphorylated Smad3 (Fig-
ure S7B), or Smad3/Smad4 complex formation (Fig-
ure S7C). In contrast, tob1a overexpression inhibited the
interaction of Smad3 with the C-terminal half of tran-
scriptional coactivator p300 in a dose-dependent man-
ner (Figure 6G). It has been previously demonstrated
that the C-terminal half of p300/CBP binds to the MH2
domain of Smad3 and augments the transcriptional ac-
tivity of Smad3 (Feng et al., 1998; Janknecht et al., 1998;
Nishihara et al., 1998; Shen et al., 1998). Thus, we pro-
pose that Tob1a inhibits Smad3-activated transcription
by preventing Smad3 from binding to coactivator p300.
Tob1a Inhibits Smad3-Induced Dorsalization
in Zebrafish Embryos
We investigated genetic interactions between tob1a and
smad3a/smad3b in zebrafish embryos. When injected
with smad3b mRNA, embryos were dorsalized with
an ovoid shape and laterally expanded somites at the5-somite stage (Figure 6H). Coinjection with tob1a
mRNA lessened smad3b-induced dorsalization, and co-
injection with tob1a-MO intensified the dorsalized phe-
notypes. These effects were confirmed by examination
of the expression of the dorsal markers chordin and
gsc as well as the ventral markers eve1 and gata2 at
the shield stage (Figure 6I; Figure S8). Similar results
were obtained with smad3a (Figure S9). Thus, tob1a
has activity opposite to that of smad3a and smad3b
during the early development of zebrafish embryos.
However, as we discuss below, tob1a may primarily
function to antagonize maternal b-catenin-mediated
signaling rather than Smad3-mediated signaling in
dorsal development.
Tob Proteins Are Functionally Conserved
We have previously identified the tob1b gene in zebra-
fish, but we failed to reveal its biological functions (Shi
et al., 2004). In mammals, there are two members of
the Tob family, Tob1 and Tob2 (Ajima et al., 2000; Yosh-
ida et al., 1997). We asked if different members of the
Tob family from various species share similar biochem-
ical properties and biological functions.
We first tested if TOB1 and b-catenin interact with
each other at their endogenous levels. b-catenin was
found to be present in the immunoprecipitate obtained
from human HEK293T cells with anti-TOB1 antibody
(Figure 7A), indicating that endogenous TOB1 and b-cat-
enin interact with each other in human cells. When coo-
verexpressed in HEK293T cells, Flag-b-catenin was
coimmunoprecipitated with Myc-tob1b, Myc-Tob1, or
Myc-Tob2 (Figure 7B). Like zebrafish tob1a, zebrafish
tob1b, mouse Tob1, or mouse Tob2 attenuated b-cate-
nin/LEF1-stimulated LEF1-luciferase expression (Fig-
ure 7C). Likewise, endogenous SMAD3 was associated
with TOB1 in human cells (Figure 7D); overexpressed ze-
brafish Tob1b, mouse Tob1, or mouse Tob2 was able to
bind to overexpressed Smad3 (Figure 7E) and inhibit
Smad3-induced CAGA12-luciferase expression (Fig-
ure 7F). Taken together, these data suggest that interac-
tion with b-catenin and Smad3 and inhibition of their
transcriptional activities are common intrinsic proper-
ties of Tob proteins (Figure 7H).
Biological functions of zebrafish tob1b and mouse
Tob1 and Tob2 were assessed by overexpression in ze-
brafish embryos. Injection with zebrafish tob1b and
mouse Tob1 or Tob2 mRNA resulted in ventralized em-
bryos with loss of the head and the notochord at 24
hpf. The dorsal markers chordin and gsc and the anterior
neuroectodermal marker otx2 all displayed a reduction
in expression, while the ventral markers bmp2b and
gata1 had expanded domains of expression (Figure 7G;
Figure S10). It appears that these tob genes all are capa-
ble of modulating dorsal tissue development upon over-
expression regardless of their origins.
Discussion
In this study, we have demonstrated that tob1a exerts
a ventralizing role in dorsoventral patterning of zebrafish
embryos. Mechanistically, Tob1a inhibits transcriptional
activity of b-catenin by preventing it from binding to
Lef1/Tcf coactivators, and it represses the transcrip-
tional activity of Smad3 by competing for cofactor p300.
Developmental Cell
234Figure 7. Tob Proteins from Different Species Have Conserved Activity
(A) Endogenous b-catenin was associated with TOB1 in human HEK293T cells. Mouse IgG was used as control.
(B) Interactions between Flag-tagged b-catenin and different Tob proteins with a Myc tag in HEK293T cells.
(C) b-catenin/LEF1-stimulated expression of the LEF1-luciferase reporter was attenuated by coexpression of individual Tob constructs. Data
were averaged from three independent experiments and are expressed as means plus standard deviations.
(D) Endogenous SMAD3 was associated with TOB1 in human HEK293T cells. Rabbit IgG was used as control. The band representing SMAD3 is
indicated by an arrow.
(E) Interactions between Flag-tagged Smad3 and different Tob proteins with a Myc tag in HEK293T cells.
(F) Smad3-induced expression of the CAGA12-luciferase reporter in Mv1lu cells was suppressed by coexpression of individual Tob constructs.
Data were averaged from three independent experiments and are expressed as means plus standard deviations.
(G) Embryos injection with 400 pg Tob1, Tob2, or tob1b mRNA showed a decrease of chordin and gsc expression at the shield stage and of otx2
expression at the bud stage, while expression of bmp2b at the shield stage and gata1 at 24 hpf was expanded. Embryos are shown in animal pole
views for chordin, in anterodorsal views for otx2, in dorsal views for gsc, and in lateral views for bmp2b and gata1. Corresponding statistical data
are shown in Figure S10.
(H) Models for antagonizing effects of Tob1 on the transcriptional activities of b-catenin and Smad3. Tob1 binds to b-catenin and precludes
b-catenin from binding the coactivator LEF1 (left). Tob1 can also bind to Smad3 and prevents the formation of the Smad3/p300 transcriptional
complex (right). BTC, basal transcription complex.Generally, tob1a overexpression is associated with
a reduction of dorsal marker gene expression and an in-
crease of ventral marker gene expression during late
blastulation and early gastrulation, while its knockdown
produces opposite effects, such as smaller, thinner tails.
Since tob1a knockdown expands the expression of thematernal b-catenin target gene boz, but is unable to res-
cue the knockdown effect of maternal b-catenin-2
(Figure 5A), we conclude that at least some of tob1a’s
ventralizing effects are attributable to its inhibition of
maternal b-catenin activity. However, we could not for-
mally exclude the possibility that tob1a also inhibits
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235zygotic Wnt/b-catenin activity in ventrolateral mesoder-
mal development after the establishment of the dorsal
organizer, because tob1a knockdown slightly enhances
the expression of the ventrolateral mesodermal marker
tbx6 (Figure 5C). The effect of tob1a on maternal Wnt/
b-catenin activity in dorsal development might obscure
its effect on zygotic Wnt/b-catenin activity in ventrolat-
eral mesodermal development, and vice versa.
Smad2/Smad3-mediated Nodal signals are involved
in organizer formation as well as dorsal mesodermal de-
velopment (Tian and Meng, 2006). Despite the fact that
tob1a possesses anti-Smad3 activity, there are a num-
ber of reasons that lead us to believe that tob1a controls
the dorsal development of zebrafish embryos mainly by
antagonizing the dorsalizing activity of maternal Wnt/b-
catenin activity. First, unlike the maternal-effect ichabod
mutants that lack the head and the notochord at 24 hpf,
embryos with defective Nodal signaling, such as sqt;cyc
double mutants (Feldman et al., 1998) and MZoep
mutants (Gritsman et al., 1999), are able to develop
a head with correct anteroposterior patterning, though
the notochord is missing. Overexpression of tob1a
results in ventralized phenotypes similar to those of
ichabod mutants, but not to sqt;cyc or MZoep mutants
(Figure S1). Similar to wild-type embryos, MZoep mu-
tants can be ventralized by tob1a overexpression (Fig-
ure S11), indicating that the ventralizing activity of
tob1a may be independent of Oep-mediated Nodal sig-
nals. Second, tob1a negatively regulates the expression
of the early dorsal marker boz (Figure 5), which is a direct
binding target of Lef1 (Leung et al., 2003) and is acti-
vated by maternal Wnt/b-catenin activity (Fekany et al.,
1999). When maternal Wnt/b-catenin activity is blocked
by knocking down b-catenin-2, boz expression is not
rescued by tob1a knockdown. On the other hand, b-cat-
enin-induced dorsalized phenotypes are rescued by
tob1a overexpression but are enhanced by tob1a
knockdown (Figure 4).
We note that knockdown of tob1a causes a slight in-
crease of the mesodermal marker ntl in the germ ring
at the shield stage and an increase of the endoderm
markers sox32 and sox17, while tob1a overexpression
exerts an opposite effect on these markers (Fig-
ure S11). Thus, we would not exclude the possibility
that tob1a inhibits the activities of Nodal/Smads in me-
sodermal and endodermal development. Because zy-
gotic expression of the Nodal genes sqt and cyc re-
quires maternal Wnt/b-catenin activity (Bellipanni
et al., 2006; Kelly et al., 2000; Shimizu et al., 2000), it is
not clear whether tob1a controls the Nodal signaling
pathway in these developmental processes directly or
indirectly.
A previous study in mice demonstrates that Tob1 in-
hibits Bmp signals in a poorly understood mechanism
in osteoblast proliferation (Yoshida et al., 2000). We
found that in zebrafish embryos tob1a overexpression
stimulated expression of the BRE-luciferase reporter,
while tob1a knockdown reduced its expression. A pos-
sible explanation is that tob1a can, in fact, activate en-
dogenous Bmp signaling via an unknown mechanism.
A more plausible explanation is that tob1a’s inhibition
of b-catenin-dependent dorsal development indirectly
results in a reduction of the dorsal expression of BMP
antagonists and thus disinhibits bmp2b.Although tob1b, another tob1 gene in zebrafish, is
also maternally expressed (Shi et al., 2004) and its over-
expression slightly ventralizes embryos, its knockdown
does not cause detectable dorsalized phenotypes (data
not shown). It is possible that these two tob1 genes in
the zebrafish genome have undergone functional parti-
tion during evolution. The mouse and human genomes
contain Tob1 and Tob2 genes, and they are maternally
expressed (Ajima et al., 2000; Ikematsu et al., 1999;
Yoshida et al., 1997). We have shown that, like zebrafish
tob1a, both mouse Tob1 and Tob2 inhibit b-catenin-me-
diated Wnt signaling in vitro and ventralize zebrafish em-
bryos upon overexpression, suggesting a role in early
embryonic patterning. In mice, Tob1 null embryos de-
velop to term without detectable defects (Yoshida
et al., 2000). This may be attributed to the redundant
function of Tob1 and Tob2 during embryogenesis. It is
therefore reasonable to suggest that double knockout
in the Tob1 and Tob2 loci would reveal their involvement
in the early patterning of mammalian embryos.
Knockdown of tob1a only causes weak dorsalized
phenotypes in zebrafish embryos. One possibility is
that maternal Tob1a protein compensates for reduction
caused by tob1a knockdown. The existence of tob2
genes in the zebrafish genome, which may have redun-
dant functions with tob1a, or other b-catenin antago-
nists, e.g., ICAT, could also compromise the net effect
of tob1a knockdown. Furthermore, if tob1a inhibits
both maternal and zygotic Wnt/b-catenin activities,
which have opposite effects on dorsal development,
the severity of the overall phenotypes caused by tob1a
knockdown may be reduced.
Tob proteins and Btg proteins share sequence homol-
ogy at their N termini as well as antiproliferative proper-
ties (Matsuda et al., 2001). Biological functions for most
Btg proteins are unknown. Wessely et al. (2005) recently
found that overexpression of xBtg-x, a Btg family mem-
ber in Xenopus, induced axis duplication and effectively
rescued the ventralizing effects caused by UV irradiation
in Xenopus embryos, and that knockdown of xBtg-x did
not cause developmental defects. They further demon-
strated that xBtg-x overexpression activated the mater-
nal b-catenin pathway in the early frog embryo and stim-
ulated b-catenin-dependent transcription in mammalian
cells, although interaction of xBtg-x with b-catenin was
not detected. We found that Tob1a was able to antago-
nize xBtg-x-enhanced expression of the LEF1-luciferase
reporter in mammalian cells (Figure S12), but overex-
pression of xBtg-x in zebrafish embryos failed to cause
detectable changes. Nevertheless, the opposite effects
of zebrafish Tob1a and Xenopus xBtg-x on b-catenin
signaling pathway may represent general differentia-
tion between Tob and Btg proteins or species-specific
divergence.
Increased Wnt signaling has been linked to tumori-
genesis (Moon et al., 2004). Mutations that result in up-
regulation of the nuclear b-catenin level and tumor de-
velopment are usually associated with malfunction or
loss-of-function of the components required for b-cate-
nin degradation. Similarly, downregulation of TOB ex-
pression as well as inactivation of the TOB protein
have been detected in human tumor tissues (Ito et al.,
2005; Iwanaga et al., 2003). Our current finding that
Tob proteins are direct antagonists of b-catenin
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an increase in the b-catenin signaling level. Therefore, it
will be of great interest to investigate the b-catenin sig-
naling level in those tumor tissues with reduced TOB
activity.
Experimental Procedures
Fish Strains
Wild-type embryos of the Tuebingen strain and the mutant strain
oeptz257 were used. MZoep mutant embryos were generated as re-
ported by Gritsman et al. (1999).
Gene Identification and Construct Generation
A plasmid containing tob1a cDNA was identified from a zebrafish
cDNA library. To screen for proteins interacting with Tob1a, we
used the BD Matchmaker Two-Hybrid System (Clonetech) to make
pGBKT7-tob1a bait and an AD fusion zebrafish cDNA library. A total
of 32 interacting proteins, one of which was b-catenin, were identi-
fied. Mouse Tob1 and Tob2 were isolated by RT-PCR from a mouse
brain cDNA library. For overexpression in mammalian cells, the cod-
ing sequence of a gene of interest was subcloned into vector pCMV5
or pCS2, with the addition of a Tag sequence at the 50 end. For mak-
ing mRNA in vitro, the coding sequence was subcloned into vector
pXT7. Mutational constructs were generated by PCR and verified
by sequencing.
Luciferase Reporter Assays
Luciferase reporter assays were performed in cell culture and in ze-
brafish embryos essentially as described previously (Sun et al.,
2006; Zhang et al., 2004).
Whole-Mount In Situ Hybridization and Microinjection
Digoxigenin-UTP-labeled antisense RNA probes were generated by
in vitro transcription and were used for whole-mount in situ hybrid-
ization. In vitro synthesis and purification of mRNA were performed
by following previously described procedures (Zhao et al., 2003). A
morpholino that targets tob1a mRNA, tob1a-MO, has a sequence
of 50-TCAAGCTGCATAGCTGCTGCGCTGC-30. A standard control
morpholino (50-CCTCTTACCTCAGTTACAATTTATA-30) from Gene
Tools, LLC, and a mutant tob1a morpholino with six mispaired
nucleotides (50-TCAAGCTGTTATTATGCTGCGCTGC-30, mispaired
nucleotides are underlined) were used as controls. The morpholino
targeting b-catenin-2 (bcat2MO) has a sequence of 50- AGCCATCG
TTGCGTCAATCCTTTAG-30, which in our hands was more effective
than MO2 used by Bellipanni et al. (2006). Wnt8MO2 has the same
sequence as that reported by Lekven et al. (2001). Microinjection
of mRNAs and morpholinos was performed as described previously
(Zhao et al., 2003).
Immunoblotting and Coimmunoprecipitation
Cell culture, immunoblotting, and coimmunoprecipitation were per-
formed as described previously (Rui et al., 2004; Zhang et al., 2004).
Mouse monoclonal antibody against human Tob1 was purchased
from Sigma-Aldrich. Rabbit polyclonal antibody against human
Smad3 was the product of ZYMED Laboratories. Anti-phospo-
Smad3 antibody was purchased from Cell Signaling Technology.
Supplemental Data
Supplemental Data include 12 figures and are available at http://
www.developmentalcell.com/cgi/content/full/11/2/225/DC1/.
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